Connect Biopharma company info

What does Connect Biopharma do?
Connect Biopharma Holdings (NASDAQ:CNTB) is an innovative biopharmaceutical company focused on the discovery, development, and commercialization of therapies for the treatment of autoimmune diseases and inflammation. With a global presence, Connect Biopharma is dedicated to advancing a pipeline of novel compounds, aiming to transform patient care in areas with significant unmet medical need. The firm's hefty commitment to research and development has led to promising projects, notably in advancing treatments targeting key checkpoints in immune response pathways. The primary objective of Connect Biopharma is to leverage its proprietary technology platforms to accelerate the development of breakthrough treatments that can offer better outcomes for patients worldwide.
Connect Biopharma company media
Company Snapshot

Is Connect Biopharma a public or private company?


How many people does Connect Biopharma employ?


What sector is Connect Biopharma in?

pie chart
Health Care

Where is the head office for Connect Biopharma?

location pin
Head Office
San Diego, United States

What year was Connect Biopharma founded?

founded flag
Year Founded
What does Connect Biopharma specialise in?
/Drug Development /Therapeutic Discovery /Immunology Research /Clinical Trials /Immunotherapy Products /Biopharmaceutical Innovation

What are the products and/or services of Connect Biopharma?

Overview of Connect Biopharma offerings
CBP-201, an investigational antibody targeting IL-4R for treating inflammatory diseases such as atopic dermatitis and asthma.
CBP-307, a novel small molecule modulator of S1P1 receptor, aimed at treating autoimmune diseases like ulcerative colitis and Crohn's disease.
CBP-174, an antagonist targeting Histamine H4 receptor, developed for addressing pruritus associated with atopic dermatitis.
CBP-233, an oral IL-4R inhibitor, designed for systemic treatment of allergic diseases.

Who is in the executive team of Connect Biopharma?

Connect Biopharma leadership team
  • Dr. Wubin  Pan M.B.A., Ph.D.
    Dr. Wubin Pan M.B.A., Ph.D.
    Co-Founder, President & Chairman of the Board of Directors
  • Dr. Zheng  Wei Ph.D.
    Dr. Zheng Wei Ph.D.
    Co-Founder, CEO & Director
  • Mr. Steven  Chan
    Mr. Steven Chan
    Chief Financial Officer
  • Mr. Jiang  Bian J.D.
    Mr. Jiang Bian J.D.
    General Counsel & Chief Compliance Officer
  • Dr. Lei  Sun Ph.D.
    Dr. Lei Sun Ph.D.
    VP of Biologics & Head of CMC
  • Dr. Raul  Collazo Ph.D.
    Dr. Raul Collazo Ph.D.
    VP & Global Head of Medical Affairs
  • Dr. Malinda V.  Longphre Ph.D.
    Dr. Malinda V. Longphre Ph.D.
    VP & Head of US Clinical Operations